Firm
A multijurisdictional claim filed by InterDigital and a new spin-off firm in Germany were also among the top talking points
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Sponsored
Sponsored
-
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico -
Sponsored by Adams & AdamsDanie Dohmen and Russell Bagnall of Adams & Adams, and in-house counsel Natasha Wright, consider the recent trends in pharmaceutical patent litigation in South Africa and discuss how the enforcement environment evolved during the pandemic
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners consider how far patent protection remains an obstacle to accessing COVID-19 vaccines
-
Sponsored by Adams & AdamsJenny Pienaar and Kareema Shaik of Adams & Adams consider pharmaceutical registration in the larger African markets, dealing with the challenges of registration and the subsequent enforcement of rights
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S explains the EBA’s G 1/21 decision
-
Sponsored by Gorodissky & PartnersVladimir Biriulin of Gorodissky & Partners considers a trademark dispute ruling by the Chamber of Patent Disputes, concerning alcoholic beverages in Class 33
